SEPARATION AGREEMENTSeparation Agreement • May 17th, 2022 • Aquestive Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledMay 17th, 2022 Company Industry JurisdictionThis Separation Agreement (the “Agreement”) is made as of May 17, 2022, by and between Aquestive Therapeutics, Inc., a Delaware corporation (the “Company”), and Keith J. Kendall (“Executive”), for the purpose of memorializing the terms and conditions of Executive’s departure from the Company’s employment.